Neuropathic pain Neuropathic pain
Conditions
Interventions
Sponsors
Hosomi Koichi
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: (1) Patients with neuropathic pain longer than 3 months after onset (2) Patients with continuous pain at upper extremity (3) Age >= 18 years (4) Patients with written consent for participation in this study
Exclusion criteria
Exclusion criteria: (1) Patients with dementia (MMSE<=23) (2) Patients with severe aphasia or cognitive dysfunction (3) Patients with severe mental illness (4) Patients with a history of epileptic seizures (5) Patients with implantable stimulators such as cardiac pacemaker (excluding implantable spinal cord stimulator) (6) Patients with metal (excluding titanium products) implants in the head (7) Patients with implantable medication devices or implantable ventricular assist devices (8) Pregnant patients (9) Patients unable to answer the questionnaires (10) Patients with complete motor paralysis of the upper extremity to be treated (11) Patients who enrolled in any other clinical trials within the last three months before obtaining consent (12) Others not applicable person determined by the investigators
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The amount of change in somatosensory threshold (assessed by Quantitative Sensory Testing (QST)) before and after each intervention | — |
Secondary
| Measure | Time frame |
|---|---|
| (1) The amount of change in motor evoked potentials (MEPs) before and after each intervention (2) Change in pain intensity (NRS) before and after each intervention (3) The amount of change in the McGill Pain Questionnaire, Short Form Version 2 (SF-MPQ2) score before and after each intervention (4) The amount of change in the degree of numbness before and after each intervention (5) Patient General Impression Criteria (PGIC) after each intervention (6) Adverse events | — |
Contacts
Public ContactMori Nobuhiko
The University of Osaka Hospital
Outcome results
None listed